Sera Prognostics Closes $20M Series B Financing Round

Jan 07, 2015

|

NEW YORK(GenomeWeb) – Sera Prognostics said today it has closed $20 million in Series B financing.

The round was led by European investment firm Chione, which is a new investor in the firm, and included current Sera investors Domain Associates, InterWest Partners, Catalyst Health Ventures, UpStart Life Sciences Capital, and Osage University Partners.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Letter Criticizes Actions

A letter criticizing actions by the US government and research institutions toward Chinese and Chinese-American scientists has garnered more than a hundred signatories.

Even Earlier Edits?

NPR reports that researchers in New York are investigating whether it is possible to edit the genomes of human sperm.

For Everyone

In an opinion piece at the Nation, Sarah Lawrence College's Laura Hercher argues that everyone should be able to access prenatal genetic testing.

Nature Studies Mystery of Remains Near Himalayan Lake, More

In Nature this week: ancient DNA uncovers presence of Mediterranean migrants at a Himalayan lake, and more.

Featured White Papers

AlbuVoid Enrichment & Antibody Depletion – Tackling the Challenges of Serum Proteomics Part II

Stroma Liquid Biopsy, a pan-cancer biomarker panel of dysregulation derived from blood

Lipid Removal Sample Prep for Cell Response Applications

Oct

23

Featured Webinar

Single-Cell Methylation Profiling of Pediatric Tumors via a Unique NGS-based Approach

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.

Menu